BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Malhotra P, Kochhar R, Vaiphei K, Wig JD, Mahmood S. Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients. World J Gastrointest Oncol 2010; 2(7): 295-303 [PMID: 21160660 DOI: 10.4251/wjgo.v2.i7.295]
URL: https://www.wjgnet.com/1948-5204/full/v2/i7/295.htm
Number Citing Articles
Lifang Hou, Xiao Zhang, Dong Wang, Andrea Baccarelli. Environmental chemical exposures and human epigeneticsInternational Journal of Epidemiology 2012; 41(1): 79 doi: 10.1093/ije/dyr154
Ning Zhou, Quankai Gu. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancerMedicine 2018; 97(12): e0195 doi: 10.1097/MD.0000000000010195
Muriel X. G. Draht, Danny Goudkade, Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic reviewClinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0461-8
Semra Demokan, Alice Chuang, Yusufhan Suoğlu, Murat Ulusan, Zubeyde Yalnız, Joseph A. Califano, Nejat Dalay. Promoter methylation and loss of p16INK4a gene expression in head and neck cancerHead & Neck 2012; 34(10): 1470 doi: 10.1002/hed.21949
EBRU ESIN YORUKER, UFUK MERT, DURSUN BUGRA, SUMER YAMANER, NEJAT DALAY. Promoter and histone methylation and p16INK4A gene expression in colon cancerExperimental and Therapeutic Medicine 2012; 4(5): 865 doi: 10.3892/etm.2012.683
Sabita N. Saldanha, Shivani Soni. Epigenetic Advancements in Cancer2016; : 1 doi: 10.1007/978-3-319-24951-3_1
Aliaa Atef, Asmaa Bedeer. Expression of α-methyl coenzyme A racemase and p16 in colorectal adenoma and adenocarcinomaEgyptian Journal of Pathology 2016; 36(1): 54 doi: 10.1097/01.XEJ.0000484374.45600.32